Nurix Therapeutics (NRIX) Current Leases (2021 - 2025)
Historic Current Leases for Nurix Therapeutics (NRIX) over the last 5 years, with Q4 2025 value amounting to $2.8 million.
- Nurix Therapeutics' Current Leases fell 6476.17% to $2.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $2.8 million, marking a year-over-year decrease of 6476.17%. This contributed to the annual value of $2.8 million for FY2025, which is 6476.17% down from last year.
- Latest data reveals that Nurix Therapeutics reported Current Leases of $2.8 million as of Q4 2025, which was down 6476.17% from $3.8 million recorded in Q3 2025.
- Nurix Therapeutics' Current Leases' 5-year high stood at $8.0 million during Q4 2024, with a 5-year trough of $2.8 million in Q4 2025.
- Moreover, its 5-year median value for Current Leases was $5.5 million (2022), whereas its average is $5.8 million.
- Per our database at Business Quant, Nurix Therapeutics' Current Leases surged by 4374.84% in 2022 and then plummeted by 6476.17% in 2025.
- Over the past 5 years, Nurix Therapeutics' Current Leases (Quarter) stood at $3.8 million in 2021, then surged by 43.75% to $5.5 million in 2022, then soared by 35.42% to $7.5 million in 2023, then rose by 7.01% to $8.0 million in 2024, then crashed by 64.76% to $2.8 million in 2025.
- Its last three reported values are $2.8 million in Q4 2025, $3.8 million for Q3 2025, and $5.2 million during Q2 2025.